2018, Número 3
<< Anterior Siguiente >>
Salud Mental 2018; 41 (3)
Effect of the polymorphism BDNF rs6265 G/A in Mexican outpatient children with autism spectrum disorders
Morales-Marín ME, Aguilar M, Albores L, Ballesteros A, Castro X, Chicalote C, Gómez A, Gutiérrez N, Lanzagorta N, López F, Márquez C, Morales N, Náfate O, Sánchez P, Balboa AM, Nicolini H
Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 117-121
Archivo PDF: 331.17 Kb.
RESUMEN
Introducción. El estudio de los trastornos del espectro autista a nivel genético es de suma importancia
para entender su origen. En México existen pocos trabajos abordados desde esta perspectiva.
Objetivo.
Investigamos el papel de la variante del gen rs6265 G/A del factor neurotrófico derivado del cerebro (
BDNF)
para el análisis del polimorfismo de un solo nucleótido en niños mexicanos con TEA por medio de un diseño
de asociación de casos y controles.
Método. Realizamos un estudio piloto mediante un análisis de casos y
controles ajustando por género, edad y ancestría.
Resultados. Nuestro estudio no encontró asociación entre
el polimorfismo del gen
BDNF rs6265 y TEA [
p = .419,
OR = 1.597 (.514, 4.967)].
Discusión y conclusión.
A nivel mundial, los resultados de estudios de asociación caso-control con el rs6265 de
BDNF son controvertidos
y no siempre se replican. Esto puede deberse a la etnicidad de nuestra población y a otros factores no
estudiados en el presente trabajo. El estudio sugiere que el SNP rs6265 no contribuye a la susceptibilidad al
TEA en población mexicana.
REFERENCIAS (EN ESTE ARTÍCULO)
Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Review Neuroscience, 16(9), 551-563. doi: 10.1038/ nrn3992
Broek, J. A., Brombacher, E., Stelzhammer, V., Guest, P. C., Rahmoune, H., & Bahn, S. (2014). The need for a comprehensive molecular characterization of autism spectrum disorders. International Journal of Neuropsychopharmacology, 17(4), 651-673. doi: 10.1017/S146114571300117X
Bryn, V., Halvorsen, B., Ueland, T., Isaksen, J., Kolkova, K., Ravn, K., & Skjeldal, O. H. (2015). Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood. European Journal of Paediatric Neurology, 19(4), 411-414. doi: 10.1016/j.ejpn.2015.03.005
Centers for Disease Control and Prevention. (2014). Community Report from the Autism and Developmental Disabilities Monitoring (ADDM) Network United States. MMWR, 63(SS2), 1-21.
Cheng, L., Ge, Q., Xiao, P., Sun, B., Ke, X., Bai, Y., & Lu, Z. (2009). Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray. International Journal of Molecular Sciences, 10(6), 2487-2500. doi: 10.3390/ijms10062487
Díaz-Anzaldúa, A., & Díaz-Martínez, A. (2013). Genetic, environmental, and epigenetic contribution to the susceptibility to autism spectrum disorders. Revista de neurologia, 57(12), 556-568.
Fombonne, E., Marcin, C., Manero, A. C., Bruno, R., Díaz, C., Villalobos, M., … Nealy, B. (2016). Prevalence of Autism Spectrum Disorders in Guanajuato, Mexico: The Leon survey. Journal of Autism and Developmental Disorders, 46(5), 1669-1685. doi: 10.1007/s10803-016-2696-6
Halepoto, D. M., Bashir, S., & LA-Ayhadi, L. (2014). Possible role of brain-derived neurotrophic factor (BDNF) in autism spectrum disorder: Current status. Journal of the College of Physicians and Surgeons Pakistan, 24(4), 274-278.
Ingram, J. L., Stodgell, C. J., Hyman, S. L., Figlewicz, D. A., Weitkamp, L. R., & Rodier, P. M. (2000). Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology, 62(6), 393-405. doi: 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.0.CO;2-V
Kasarpalkar, N. J., Kothari, S. T., & Dave, U. P. (2014). Brain-Derived Neurotrophic Factor in children with Autism Spectrum Disorder. Ann Neurosci, 21(4), 129- 133. doi:10.5214/ans.0972.7531.210403
Kim, B. N., Cummins, T. D., Kim, J. W., Bellgrove, M. A., Hong, S. B., Song, S. H., . . . Shin, Y. M. (2011). Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with a better response to OROSMPH in Korean ADHD children. International Journal of Neuropsychopharmacology, 14(10), 1399-1410. doi: 10.1017/S146114571100099X
Lai, M. C., Lombardo, M. V., Chakrabarti, B., & Baron-Cohen, S. (2013). Subgrouping the autism “spectrum”: reflections on DSM-5. PLoS Biology, 11(4), e1001544. doi: 10.1371/journal.pbio.1001544
Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659-685.
Márquez, L., Camarena, B., Hernández, S., Lóyzaga, C., Vargas, L., & Nicolini, H. (2013). Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder. European Neuropsychopharmacology, 23(11), 1600-1605. doi: 10.1016/j.euroneuro.2013.08.001
Márquez-Caraveo, M. (2009). Guía clínica: Trastornos Generalizados del Desarrollo. Guías del Hospital Psiquiátrico Infantil “Dr. Juan N. Navarro”.
Meng, W. D., Sun, S. J., Yang, J., Chu, R. X., Tu, W., & Liu, Q. (2016). Elevated Serum Brain-Derived Neurotrophic Factor (BDNF) but not BDNF Gene Val66Met Polymorphism Is Associated with Autism Spectrum Disorders. Molecular Neurobiology, 54(2), 1167-1172. doi: 10.1007/s12035-016-9721-9
Morales-Marín, M. E., Genis-Mendoza, A. D., Tovilla-Zarate, C. A., Lanzagorta, N., Escamilla, M., & Nicolini, H. (2016). Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population. Neuropsychiatric Disease and Treatment, 12, 1843-1848. doi: 10.2147/NDT.S104654
Nishimura, K., Nakamura, K., Anitha, A., Yamada, K., Tsujii, M., Iwayama, Y., … Iwata, N. (2007). Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism. Biochemical and Biophysical Research Communications, 356(1), 200-206. doi: 10.1016/j.bbrc.2007.02.135
Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics, 90(3), 397-406. doi: 10.1016/j. ygeno.2007.05.004
Raznahan, A., Toro, R., Proitsi, P., Powell, J., Paus, T., P, F. B., & Murphy, D. G. (2009). A functional polymorphism of the brain derived neurotrophic factor gene and cortical anatomy in autism spectrum disorder. Journal of Neurodevelopmental Disorders, 1(3), 215-223. doi: 10.1007/s11689-009-9012-0
Ricci, S., Businaro, R., Ippoliti, F., Vasco, V. R., Massoni, F., Onofri, E., … Archer, T. (2013). Altered cytokine and BDNF levels in autism spectrum disorder. Neuro toxicity Research, 24(4), 491-501. doi: 10.1007/s12640-013-9393-4
Sheikh, H. I., Hayden, E. P., Kryski, K. R., Smith, H. J., & Singh, S. M. (2010). Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR. Psychiatric Genetics, 20(3), 109-112. doi: 10.1097/YPG.0b013e32833a2038
World Health Organization. (2013). Meeting report: autism spectrum disorders and other developmental disorders: from raising awareness to building capacity. Geneva: World Health Organization. Retrieved from http://www.who.int/iris/ handle/10665/103312
Yang, X., Liu, P., Sun, J., Wang, G., Zeng, F., Yuan, K., ... Tian, J. (2012). Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One, 7(6), e37777. doi: 10.1371/journal.pone.0037777
Yoo, H. J., Yang, S. Y., Cho, I. H., Park, M., & Kim, S. A. (2014). Polymorphisms of BDNF gene and autism spectrum disorders: family based association study with Korean trios. Psychiatry Investigation, 11(3), 319-324. doi: 10.4306/ pi.2014.11.3.319
Zhai, J., Yu, Q., Chen, M., Gao, Y., Zhang, Q., Li, J., ... Li, X. (2013). Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia. International Journal of Clinical and Experimental Pathology, 6(8), 1617-1623.